LRRK2 in Parkinson's disease: protein domains and functional insights

Trends in Neurosciences
Ignacio F MataKathleen A Gallo

Abstract

Parkinson's disease (PD) is the most common motor neurodegenerative disease. Mutations in the gene encoding leucine-rich repeat kinase 2 (LRRK2) have been linked recently with autosomal-dominant parkinsonism that is clinically indistinguishable from typical, idiopathic, late-onset PD. Thus, the protein LRRK2 has emerged as a promising therapeutic target for treatment of PD. LRRK2 is extraordinarily large and complex, with multiple enzymatic and protein-interaction domains, each of which is targeted by pathogenic mutations in familial PD. This review places the PD-associated mutations of LRRK2 in a structural and functional framework, with the ultimate aim of deciphering the molecular basis of LRRK2-associated pathogenesis. This, in turn, should advance our understanding and treatment of familial and idiopathic PD.

References

Feb 1, 1996·Journal of Molecular Graphics·R KoradiK Wüthrich
Sep 1, 1997·Nucleic Acids Research·S F AltschulD J Lipman
Sep 23, 1997·Cell·B J CanagarajahE J Goldsmith
Aug 4, 1999·Trends in Biochemical Sciences·J Cherfils, P Chardin
Mar 31, 2000·Trends in Cell Biology·J M ShieldsC J Der
Feb 24, 2001·Protein Science : a Publication of the Protein Society·L YuT F Smith
Jun 2, 2001·Genome Biology·H Stenmark, V M Olkkonen
Jul 18, 2001·The Journal of Biological Chemistry·W LiK L Guan
Sep 12, 2001·Journal of Structural Biology·M A AndradeC P Ponting
Dec 26, 2001·Current Opinion in Structural Biology·B Kobe, A V Kajava
May 23, 2002·Cell·Morgan Huse, John Kuriyan
Jul 20, 2002·Archives of Biochemistry and Biophysics·Amardeep S Dhillon, Walter Kolch
Sep 5, 2002·Nature Reviews. Molecular Cell Biology·Kathleen A Gallo, Gary L Johnson
Dec 10, 2002·Science·G ManningS Sudarsanam
May 23, 2003·Bioinformatics·Krzysztof GinalskiLeszek Rychlewski
Jun 6, 2003·Journal of Molecular Biology·Mohammad Reza AhmadianKlaus Scheffzek
Jul 9, 2003·Annals of the New York Academy of Sciences·Stanley Fahn
Oct 24, 2003·Protein Science : a Publication of the Protein Society·Mark E ZweifelDoug Barrick
Dec 5, 2003·Biochimica Et Biophysica Acta·Leonard Bosgraaf, Peter J M Van Haastert
Jan 28, 2004·Annual Review of Pharmacology and Toxicology·Leo H WangEugene M Johnson
May 14, 2004·Annual Review of Biophysics and Biomolecular Structure·Michael B Yaffe, Stephen J Smerdon
May 21, 2004·Protein Science : a Publication of the Protein Society·Leila K MosaviZheng-Yu Peng
Jul 28, 2004·Journal of Molecular and Cellular Cardiology·Songhai ChenHeidi E Hamm
Oct 29, 2004·Journal of Cell Science·Martin Schwartz
Nov 3, 2004·Nature Reviews. Molecular Cell Biology·Claudia WellbrockRichard Marais
Nov 16, 2004·Neuron·Coro Paisán-RuízAndrew B Singleton
Dec 2, 2004·Biochimica Et Biophysica Acta·Keiji TanakaYoshikuni Mizuno
Feb 1, 2005·Lancet·William C NicholsUNKNOWN Parkinson Study Group-PROGENI investigators
Feb 1, 2005·Lancet·Alessio Di FonzoUNKNOWN Italian Parkinson Genetics Network
Feb 1, 2005·Lancet·William P GilksNicholas W Wood
Mar 9, 2005·Trends in Biochemical Sciences·Etienne Meylan, Jürg Tschopp
Apr 7, 2005·Lancet·Mathias ToftMatthew J Farrer
Apr 7, 2005·Lancet·Mario Albrecht
Apr 27, 2005·Annals of Neurology·Jan O AaslyMatthew Farrer
May 10, 2005·Annals of Neurology·Manabu FunayamaFumiya Obata
Jun 1, 2005·Neuroscience Letters·Ignacio F MataVictoria Alvarez

❮ Previous
Next ❯

Citations

Oct 26, 2013·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Weidong LeJoseph Jankovic
Jan 28, 2014·Analytical Biochemistry·Rafael G SilvaAnn Aulabaugh
Oct 20, 2010·ASN Neuro·Aiwu ChengMark P Mattson
Dec 20, 2013·Proceedings of the National Academy of Sciences of the United States of America·Kathrin MudaFriedrich W Herberg
Feb 11, 2014·Proceedings of the National Academy of Sciences of the United States of America·Quyen Q Hoang
Mar 5, 2014·Proceedings of the National Academy of Sciences of the United States of America·Jingling LiaoQuyen Q Hoang
Oct 1, 2010·Journal of Movement Disorders·Udhaya Kumari, Eng-King Tan
Nov 14, 2014·Molecular Neurodegeneration·Jie-Qiong LiJin-Tai Yu
Jan 21, 2014·Antioxidants & Redox Signaling·Chris McKinnon, Sarah J Tabrizi
Sep 7, 2007·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·D A GrimesD E Bulman
Jun 25, 2014·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Iakov N Rudenko, Mark R Cookson
Dec 22, 2007·Neuro-Signals·Benoit I Giasson, Vivianna M Van Deerlin
Dec 2, 2006·Molecular Neurodegeneration·Xiongwei ZhuShu G Chen
Jan 18, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Xiqun ChenRobert E Burke
Jan 31, 2008·Proceedings of the National Academy of Sciences of the United States of America·Junpeng DengMark R Cookson
Mar 28, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Lizhen WangHuaibin Cai
Apr 23, 2008·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Yoshikuni MizunoHideki Mochizuki
Mar 11, 2009·Antioxidants & Redox Signaling·Saurabh Sen, Andrew B West
Jun 19, 2009·PloS One·Xiaodong Ding, Matthew S Goldberg
Jul 25, 2009·Human Molecular Genetics·Rosa M SanchoKirsten Harvey
Oct 31, 2009·Nature Reviews. Drug Discovery·Laura K ChicoD Martin Watterson
Nov 6, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Loukia ParisiadouHuaibin Cai
Dec 31, 2009·PloS One·Nathan D JorgensenWilliam T Dauer
Mar 30, 2010·Eukaryotic Cell·Wouter N van Egmond, Peter J M van Haastert
Apr 14, 2010·PLoS Genetics·Yulan XiongDarren J Moore
Sep 30, 2010·Molecular & Cellular Proteomics : MCP·Andrea MeixnerMarius Ueffing
Apr 2, 2011·The Journal of Biological Chemistry·Diane ChanBenjamin Wolozin
May 24, 2011·Parkinson's Disease·Tianxia LiWanli W Smith
Jan 10, 2012·Human Molecular Genetics·Xinglong WangXiongwei Zhu
Dec 18, 2013·PloS One·Yih-Ru WuChiung-Mei Chen
Mar 24, 2012·Current Neurology and Neuroscience Reports·Elpida Tsika, Darren J Moore
Jan 15, 2009·Acta Neuropathologica·Gabriel Santpere, Isidre Ferrer
Aug 22, 2013·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Liang HuangHoward J Federoff
Apr 23, 2013·Stem Cells and Development·Lamia'a BahnassawyJens C Schwamborn

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.